The primary advantage of CAR T-cell therapy is its ability to provide highly personalized treatment that is specific to the patient's cancer. This targeted approach can lead to remissions in cases where other treatments have failed. Additionally, CAR T-cell therapy continues to work in the body after infusion, providing ongoing surveillance and attack against cancer cells.
